| Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer C Henzler, Y Li, R Yang, T McBride, Y Ho, C Sprenger, G Liu, I Coleman, ... Nature communications 7 (1), 13668, 2016 | 162 | 2016 |
| Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation RS Liao, S Ma, L Miao, R Li, Y Yin, GV Raj Translational andrology and urology 2 (3), 187, 2013 | 129 | 2013 |
| Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer H Singhal, ME Greene, G Tarulli, AL Zarnke, RJ Bourgo, M Laine, ... Science Advances 2 (6), e1501924, 2016 | 126 | 2016 |
| A patient‐derived explant (PDE) model of hormone‐dependent cancer MM Centenera, TE Hickey, S Jindal, NK Ryan, P Ravindranathan, ... Molecular oncology 12 (9), 1608-1622, 2018 | 105 | 2018 |
| Plasmodium yoelii: distinct CD4+ CD25+ regulatory T cell responses during the early stages of infection in susceptible and resistant mice Y Wu, Q Wang, L Zheng, H Feng, J Liu, S Ma, Y Cao Experimental parasitology 115 (3), 301-304, 2007 | 100 | 2007 |
| KDM4/JMJD2 histone demethylase inhibitors block prostate tumor growth by suppressing the expression of AR and BMYB-regulated genes L Duan, G Rai, C Roggero, QJ Zhang, Q Wei, SH Ma, Y Zhou, J Santoyo, ... Chemistry & biology 22 (9), 1185-1196, 2015 | 81 | 2015 |
| IFNγ-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via miRNA processing UG Lo, RC Pong, D Yang, L Gandee, E Hernandez, A Dang, CJ Lin, ... Cancer research 79 (6), 1098-1112, 2019 | 80 | 2019 |
| Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs TP Knutson, TH Truong, S Ma, NJ Brady, ME Sullivan, G Raj, ... Journal of Hematology & Oncology 10, 1-24, 2017 | 78 | 2017 |
| The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer S Wang, RK Kollipara, CG Humphries, SH Ma, R Hutchinson, R Li, ... Oncotarget 7 (40), 64921, 2016 | 54 | 2016 |
| Breast tumor kinase (Brk/PTK6) is induced by HIF, glucocorticoid receptor, and PELP1-mediated stress signaling in triple-negative breast cancer TM Regan Anderson, SH Ma, GV Raj, JA Cidlowski, TM Helle, ... Cancer research 76 (6), 1653-1663, 2016 | 54 | 2016 |
| Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers GV Raj, GR Sareddy, S Ma, TK Lee, S Viswanadhapalli, R Li, X Liu, ... Elife 6, e26857, 2017 | 53 | 2017 |
| EC359: a first-in-class small-molecule inhibitor for targeting oncogenic LIFR signaling in triple-negative breast cancer S Viswanadhapalli, Y Luo, GR Sareddy, B Santhamma, M Zhou, M Li, ... Molecular cancer therapeutics 18 (8), 1341-1354, 2019 | 52 | 2019 |
| Electrical impedance measurements of biological cells in response to external stimuli A Mansoorifar, A Koklu, S Ma, GV Raj, A Beskok Analytical chemistry 90 (7), 4320-4327, 2018 | 43 | 2018 |
| Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer B Wang, UG Lo, K Wu, P Kapur, X Liu, J Huang, W Chen, E Hernandez, ... International journal of cancer 141 (10), 2121-2130, 2017 | 30 | 2017 |
| Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice S Ma, L Zheng, Y Liu, S Guo, H Feng, G Chen, D Li, J Wang, Y Cao Experimental parasitology 116 (3), 266-272, 2007 | 29 | 2007 |
| Therapeutic effect of α-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice SH Ma, GG Chen, J Yip, PBS Lai Gene therapy 17 (7), 905-912, 2010 | 26 | 2010 |
| A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells CM Roggero, L Jin, S Cao, R Sonavane, NG Kopplin, HQ Ta, DN Ekoue, ... Oncogene 40 (6), 1106-1117, 2021 | 24 | 2021 |
| Taxol induces Brk-dependent prosurvival phenotypes in TNBC cells through an AhR/GR/HIF–driven signaling axis TM Regan Anderson, S Ma, C Perez Kerkvliet, Y Peng, TM Helle, ... Molecular Cancer Research 16 (11), 1761-1772, 2018 | 19 | 2018 |
| Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers S Viswanadhapalli, S Ma, GR Sareddy, TK Lee, M Li, C Gilbreath, X Liu, ... Breast Cancer Research 21, 1-15, 2019 | 17 | 2019 |
| Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress X Liu, S Viswanadhapalli, S Kumar, TK Lee, A Moore, S Ma, L Chen, ... Nature Cancer 3 (7), 866-884, 2022 | 14 | 2022 |
Ross S. LiaoCleveland Clinic Glickman Urological and Kidney InstituteE-mail confirmado em ccf.org
